Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine for secondary prevention after ischemic stroke
ChiCTR-TRC-12002078Phase 4Completed
- Sponsor
- Shenzhen People's Hospital
- Start
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of fluoxetine in ischemic stroke (2 arms), sponsored by Shenzhen People's Hospital. Primary endpoint: Recurrence rate of cerebral infarction within 3 months. Started Jun 2011; status: completed.
02
Drugs
fluoxetine
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR-TRC-12002078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002078.